The Marketplace Sticker Shock

Jonathan Szkotak, PharmD

If you looked at American health insurance data this time last year, things looked strangely optimistic. Enrollment was at an all-time high, and federal subsidies were flowing. Then 2026 arrived, the federal training wheels came off, and reality reasserted itself with its usual brute force. The last twelve months have been a masterclass in what happens when artificial financial cushions disappear, leaving consumers to navigate a market that looks less like a safety net and more like a high-wire act.

If you looked at American health insurance data this time last year, things looked strangely optimistic. Enrollment was at an all-time high, and federal subsidies were flowing. Then 2026 arrived, the federal training wheels came off, and reality reasserted itself with its usual brute force. The last twelve months have been a masterclass in what happens when artificial financial cushions disappear, leaving consumers to navigate a market that looks less like a safety net and more like a high-wire act.

The individual Affordable Care Act (ACA) market spent the first half of the year experiencing a massive financial hangover. At the end of 2025, the enhanced federal premium tax credits expired. Predictably, enrollment plummeted from 22 million to just over 19 million as consumers realized their monthly premiums were suddenly doubling... a fun surprise for anyone trying to manage a household budget.

To stay insured, millions of people did the only logical thing available: they downgraded their plans. The mass migration from Silver to Bronze plans managed to keep monthly premiums manageable, but it transferred the financial pain to the backend. Average deductibles spiked by over a thousand dollars, pushing the typical Bronze deductible near $3,800. How many people have an extra four grand laying around that they don't know what to do with.... every month? Functionally, this turns health insurance into catastrophe insurance. You are covered if a piano falls on you, but a routine sinus infection is entirely on your dime. At some point I'll write about the rise of online treatment programs like Amazon's medical establishment, but for now we'll focus on the insurance market as is. The sharpest drop-offs occurred among young adults and those just above the poverty line, the exact demographics needed to keep the risk pool stable.

The public sector managed to find its own ways to trim the rolls. National Medicaid enrollment dropped by roughly 6% over the last year, driven largely by the administrative friction introduced in the mid-2025 federal budget reconciliation bill. The statutory rules mandated semi-annual renewal periods instead of annual ones for expansion populations, while clearing the way for mandatory work requirements. Adding paperwork and compliance loops to a bureaucracy is an incredibly effective way to reduce enrollment without actually changing anyone's underlying financial reality. Several states spent the last few months eagerly applying for waivers to fast-track these restrictions, ensuring that keeping public coverage now requires a steady stream of administrative stamina.

For those covered through their employers, the news was not much better. Small and mid-sized businesses are currently absorbing double-digit premium increases for their 2026 plans.

Two main culprits dominate the actuarial spreadsheets. First, persistent healthcare labor shortages have allowed hospital systems to demand higher reimbursement rates during contract renewals. Second, there is the undeniable impact of specialty pharmacy spending. Insurers spent the last year watching utilization curves for GLP-1 receptor agonists shoot straight into the stratosphere. Employers and insurers are caught in a classic structural bind: employees view coverage for weight-loss therapeutics as a baseline benefit, while finance departments view the total invoice with sheer panic.

The strategic takeaway from the last twelve months is straightforward. Gains in American healthcare coverage are entirely dependent on direct federal subsidization. Once the funding retreats, the market rapidly course-corrects through enrollment attrition and higher out-of-pocket exposure. For the millions of Americans now holding high-deductible Bronze plans, having insurance is no longer synonymous with being able to afford care.

Ultimately, the 2025 federal budget reconciliation act, formally titled the One Big Beautiful Bill Act... because Washington loves irony... functioned as the legislative pivot point that systematically unwound a decade of public insurance expansion. By trimming nearly a trillion dollars from projected federal Medicaid outlays over the next ten years, the law fundamentally altered the baseline economics of public coverage.  

The policy achieved its fiscal diet through the strategic deployment of administrative friction, relying on compliance mechanisms rather than direct eligibility repeals. The introduction of semi-annual eligibility re-determinations and mandatory 80-hour-per-month work requirements transformed Medicaid into a complex compliance exercise. For states, the tightening of provider tax caps and restrictions on state-directed managed care payments squeezed matching funds, forcing state regulators to look at optional benefits like adult dental and vision with a budget-cutting eye.  

On the individual market side, the bill's deliberate silence on the expiring enhanced ACA tax credits, combined with aggressive new pre-enrollment verification loops, effectively choked off automatic re-enrollments. The overarching legacy of the 2025 budget is a structural realignment of healthcare risk, shifting the financial liability away from the federal ledger and directly onto states, health systems, and consumers... who now need a steady stream of administrative stamina just to keep their coverage.

Jonathan Szkotak, PharmD, is a patient access and healthcare strategist and managed care consultant with over a decade of experience in formulary development, clinical analytics, and patient access policy. He has chaired multiple Pharmacy & Therapeutics Committees and led data-driven programs to improve drug coverage and healthcare equity. His work blends clinical insight with operational expertise to shape smarter healthcare delivery.

Learn more at www.jonathanszkotak.com or follow him on LinkedIn or Twitter.

References

1. KFF. ACA Marketplace enrollment is down by 3 million after big jump in premium payments. KFF Quick Insights. June 29, 2026. Accessed July 9, 2026. https://www.kff.org/quick-insights/aca-marketplace-enrollment-is-down-by-3-million-after-big-jump-in-premium-payments/

2. Assistant Secretary for Planning and Evaluation (ASPE). ACA Exchange Enrollment in 2026. US Department of Health and Human Services; June 26, 2026. https://aspe.hhs.gov/reports/aca-exchange-enrollment-2026

3. KFF. What we know so far about 2026 ACA Marketplace enrollment, premiums, and deductibles. KFF Issue Brief. May 19, 2026. Accessed July 9, 2026. https://www.kff.org/affordable-care-act/what-we-know-so-far-about-2026-aca-marketplace-enrollment-premiums-and-deductibles/

4. OPEN MINDS. Medicaid, CHIP & ACA enrollment drops by more than eight million. OPEN MINDS Market Intelligence. July 7, 2026. Accessed July 9, 2026. https://openminds.com/market-intelligence/news/medicaid-chip-aca-enrollment-drops-by-more-than-eight-million/

5. American Medical Association. Changes to Medicaid, the ACA and other key provisions of the One Big Beautiful Bill Act. AMA Health Care Advocacy. June 4, 2026. Accessed July 9, 2026. https://www.ama-assn.org/health-care-advocacy/federal-advocacy/changes-medicaid-aca-and-other-key-provisions-one-big

6. Bipartisan Policy Center. 2025 reconciliation debate: health provisions—the Senate. BPC Explainer. June 18, 2025. Accessed July 9, 2026. https://bipartisanpolicy.org/explainer/2025-reconciliation-debate-health-provisions-senate/